Reacts with
Human
ELISA type
competitive
Assay sensitivity
1.0pg per ml
Detection range
100-2500pg per ml
Antigen
Regulator of G protein signaling 20(RGS20)
Original name
Human Regulator of G protein signaling 20(RGS20) ELISA kit
Test
BlueGen ELISAs supplies other types of Assays as 1.ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Reproducibility of the results
Intra-Assay: Coefficient of variability is lower than 10%; Inter-Assay: Coefficient of variability is lower than 15%
Tips
The product Assay kit for human Regulator of G protein signaling 20(RGS20) (ELISA) is intended to be used for research purposes only. It is not testesd for application in diagnostics.
Cross reactivity
There is no indicative cross reactivity between the antigen and its analogues detected during the testing of the product Assay kit for human Regulator of G protein signaling 20(RGS20) (ELISA)
Product storage
The product Assay kit for human Regulator of G protein signaling 20(RGS20) (ELISA) should be kept between two and eight degrees Celsius to ensure the retention of the stability and reactivity of the reagents included in the kit.
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.
Description
Cell nucleus signaling proteins and molecules are part of a complex system of communication that governs basic cellular activities and coordinates cell actions. The ability of cells to perceive and correctly respond to their microenvironment is the basis of development, tissue repair, and immunity as well as normal tissue homeostasis. Errors in cellular information processing are responsible for diseases such as cancer, autoimmunity, and diabetes. By understanding cell signaling, diseases may be treated effectively and, theoretically, artificial tissues may be created.
